Search

everythinglearnresearchcommunity

for

Search:↓

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

PLD is an effective and safer alternative for treating breast cancer.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

CEC levels may be a useful marker for predicting prostate cancer progression.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that better training and education are needed for proper cancer screening and criticizes the GMC's inaction as harmful to clinical ethics in the UK.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.